B.Riley Financial Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $109

Moomoo News20:32 ET · Ratings

Viking Therapeutics: Strong Potential in Obesity and Type 2 Diabetes Market With Innovative VK2735 Program

TipRanks20:15 ET

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

Analyst UpgradesNov 20 13:26 ET

Viking Therapeutics Is More Than Just a Weight-loss Stock, and That's Drawing Cheers

MarketWatchNov 20 12:06 ET

Express News | Viking Therapeutics Shares Rise 4.6% Premarket After Co Presents Detailed Mid-Stage Data for Experimental Liver Disease Drug

ReutersNov 20 05:06 ET

Trending Stocks Today | Tonix Pharmaceuticals Surges 58.63% Post-Market

Moomoo NewsNov 19 18:00 ET